mortality/aging
• ratio between wildtype and heterozygous mice is about 1:1.5, however no neonatal lethality is observed, indicating that some embryos die in utero, even though none were found dead before E14.5
|
immune system
• a few heterozygotes exhibit an increase in thrombocyte numbers and in general, the platelet counts show a wider scatter than in wildtype
|
hematopoietic system
• a few heterozygotes exhibit an increase in thrombocyte numbers and in general, the platelet counts show a wider scatter than in wildtype
|
• bone marrow shows hypercellularity of red blood cell precursors and an increase in the relative ratio of erythroblast/myeloid precursors
|
• subset of heterozygotes exhibit megakaryocyte dyspoiesis, including cells with multiple separated nuclei, cells with small oval nuclei in mature cytoplasm, or cells with hypolobated nuclei
• a few heterozygotes show an increase in megakaryocyte numbers
|
• high proportion of dysplastic erythroid precursors, which include binucleated cells, cells with abnormal mitosis and cells with nuclear fragmentation and irregular nuclear contours in the bone marrow
• bone marrow shows an increase in the percentage of immature erythroblasts and a decrease in cells in the advanced stages of erythroid differentiation
|
• seen in about 80% of 6-18 month old heterozygotes
|
anisocytosis
(
J:101494
)
• increase in red cell distribution width indicating an overall increase in size of erythrocytes, however did not observe reticulocytosis or differences in red blood cell counts or hemoglobin levels
|
• a few heterozygotes exhibit very low reticulocyte counts
|
cellular
• early passage MEFs (P2-P6) have decreased cell proliferation rates, however later passage cells (P5-P8) have higher proliferation rates and show an immortal phenotype
|
• MEFs contain supernumery centrosomes
• later passage MEFs exhibit high levels of anueploidy
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
myelodysplastic syndrome | DOID:0050908 |
OMIM:614286 |
J:101494 |